FOUNDER PROFILE

Jean-Luc Treillou

Jean-Luc Treillou

Jean-Luc Treillou

Jean-Luc Treillou is co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Since January 2019, he has also acted as an advisor and member of the strategic committee of IT security company Eshard. Prior to co-founding TreeFrog, Treillou founded YSOPIA Bioscience in 2011, where he was CEO until he left in 2021, and Chairman of the Board from 2018. Between 2009 and 2013 he held the posts of General Manager and Chairman of the Board at French R&D company Nutrionix.

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading
LOG IN
RECOMMENDED
Ivan Tambunan

Founder

Ivan Tambunan

Co-founder and CEO of Akseleran

Guritno Adi Saputra

Founder

Guritno Adi Saputra

Co-founder and CTO of PrivyID

Jose Vidal Obón

Founder

Jose Vidal Obón

Co-founder, CEO & CFO Spain of Nutrinsect

RECOMMENDED

Ivan Tambunan

Founders

Ivan Tambunan

Co-founder and CEO of Akseleran

Guritno Adi Saputra

Founders

Guritno Adi Saputra

Co-founder and CTO of PrivyID

Jose Vidal Obón

Founders

Jose Vidal Obón

Co-founder, CEO & CFO Spain of Nutrinsect

Gift This Article

The gift link can be opened by one recipient only.

You have 19 gift credits left this month

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.